JPWO2020262325A1 - - Google Patents

Info

Publication number
JPWO2020262325A1
JPWO2020262325A1 JP2021526988A JP2021526988A JPWO2020262325A1 JP WO2020262325 A1 JPWO2020262325 A1 JP WO2020262325A1 JP 2021526988 A JP2021526988 A JP 2021526988A JP 2021526988 A JP2021526988 A JP 2021526988A JP WO2020262325 A1 JPWO2020262325 A1 JP WO2020262325A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021526988A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020262325A1 publication Critical patent/JPWO2020262325A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021526988A 2019-06-28 2020-06-22 Pending JPWO2020262325A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019121736 2019-06-28
PCT/JP2020/024469 WO2020262325A1 (ja) 2019-06-28 2020-06-22 雌の抗老化剤

Publications (1)

Publication Number Publication Date
JPWO2020262325A1 true JPWO2020262325A1 (zh) 2020-12-30

Family

ID=74061396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021526988A Pending JPWO2020262325A1 (zh) 2019-06-28 2020-06-22

Country Status (4)

Country Link
JP (1) JPWO2020262325A1 (zh)
CN (1) CN114007618A (zh)
TW (1) TW202114674A (zh)
WO (1) WO2020262325A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108642001B (zh) * 2018-05-08 2022-09-02 中国农业科学院北京畜牧兽医研究所 一种提高牛性控冻精体外受精能力的方法
CN113693023B (zh) * 2021-09-03 2022-09-02 河南省农业科学院畜牧兽医研究所 一种提高超期不发情后备母猪入群效率的处理方法
CN113813261A (zh) * 2021-09-15 2021-12-21 常州市妇幼保健院 吡咯喹啉醌在预防和/或治疗女性生殖功能障碍的用途
CN114306360A (zh) * 2021-11-12 2022-04-12 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 蓝靛果花青素提取物在制备改善多囊卵巢综合征的药物和/或保健品中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101885725A (zh) * 2009-05-12 2010-11-17 江苏道琪生物科技有限公司 吡咯喹啉醌钠盐衍生物及其制备方法
JP2011246442A (ja) * 2010-04-28 2011-12-08 Rohto Pharmaceutical Co Ltd 光老化抑制剤および皮膚菲薄化抑制剤
BR112013033797A2 (pt) * 2011-06-29 2017-02-14 Harvard College composição, célula isolada, mitocôndria isolada , métodos de preparo de um oócito, de fertilização in vitro, de melhora de fertilidade em um indivíduo, de sustentação de desenvolvimento embrionário, de recuperação ou aumento de função ovariana em um indivíduo, de preparo de um tecido ou célula do mesmo, e de produção de um oócito, oócito, e, agente bioenergético
WO2015089656A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
EP3199154A4 (en) * 2014-09-22 2018-02-28 National University Corporation Nagoya University Novel life-prolonging agent, life-prolonging method making use of same, novel dual oxidase activator, method for activating dual oxidase, manufacture of life-prolonging agent, and manufacture of dual oxidase activator
JP2017114844A (ja) * 2015-12-22 2017-06-29 三菱瓦斯化学株式会社 認識能力向上食品
CN105853502A (zh) * 2016-05-11 2016-08-17 深圳市太生源健康产业有限公司 吡咯喹啉醌在改善女性生殖系统内环境的应用
CN107174583B (zh) * 2017-06-09 2020-07-31 南京医科大学 吡咯喹啉醌预防和/或治疗雄性生殖功能障碍的用途

Also Published As

Publication number Publication date
WO2020262325A1 (ja) 2020-12-30
CN114007618A (zh) 2022-02-01
TW202114674A (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
BR112021017339A2 (zh)
BR112021013854A2 (zh)
BR112021018450A2 (zh)
BR112021017939A2 (zh)
BR112021017892A2 (zh)
BR112021017738A2 (zh)
BR112021017782A2 (zh)
JPWO2020262325A1 (zh)
BR112021018168A2 (zh)
BR112021017728A2 (zh)
BR112021017234A2 (zh)
BR112021017355A2 (zh)
BR112021017173A2 (zh)
BR112021018102A2 (zh)
BR112021017083A2 (zh)
BR112021017637A2 (zh)
BR112021018452A2 (zh)
BR112021012348A2 (zh)
BR112021018250A2 (zh)
BR112021018084A2 (zh)
BR112021018093A2 (zh)
BR112021017703A2 (zh)
BR112021018484A2 (zh)
BR112021017732A2 (zh)
BR112021017949A2 (zh)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240312

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240509